Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.
暂无分享，去创建一个
R. Schooley | R. Lempicki | C. Rinaldo | S. Wahl | D. Asmuth | R. Murphy | R. Pollard | Xiao-dong Li | S. Rosenkranz | N. Thielman | Jennifer Janik | S. Kottilil | Ellen S. Chan | Yoninah S. Cramer | J. Lertora | Jessica E Shore | Yaa Simpson | J. Shore